⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19634749 | 0.80 | CYP3A4 (0.30) | — | |
| SCHEMBL18657107 | 0.79 | — | — | |
| SCHEMBL1097996 | 0.78 | — | — | |
| SCHEMBL27472050 | 0.76 | — | — | |
| SCHEMBL14982941 | 0.76 | — | — | |
| SCHEMBL14198889 | 0.76 | TSHR (0.33) | — | |
| SCHEMBL35006 | 0.76 | — | — | |
| Ammonia Solution, Strong SCHEMBL28027304 | 0.74 | CYP3A4 (0.32) | — | |
| SCHEMBL8675416 | 0.74 | — | — | |
| SCHEMBL21132513 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11155672-B2 | Surface treatment agent | DAIKIN INDUSTRIES, LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| US-20200046711-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NONALCOHOLIC STEATOHEPATITIS, HEPATIC FIBROSIS, AND LIVER CIRRHOSIS, COMPRISING ADENOSINE DERIVATIVES | FUTURE MEDICINE CO., LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
| EP-3533452-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NONALCOHOLIC STEATOHEPATITIS, HEPATIC FIBROSIS, AND LIVER CIRRHOSIS, COMPRISING ADENOSINE DERIVATIVES | Future Medicine Co., Ltd. (KR) | 2019-09-04 | — | — | EP | disclosed |
| US-20180162985-A1 | SURFACE TREATMENT AGENT | DAIKIN INDUSTRIES, LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-9631045-B2 | Polycarbodiimides having onium salt groups | PPG INDUSTRIES OHIO, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| EP-2646043-B1 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION | S&T GLOBAL INC (US) | 2017-02-15 | — | — | EP | disclosed |
| US-9018371-B2 | Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient | FM THERAPEUTICS CO., LTD. (KR) | 2015-04-28 | — | — | US | disclosed |
| EP-2142549-B1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM THERAPEUTICS CO LTD (KR) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012172093-A1 | DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012021796-A2 | NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION | S&T GLOBAL, INC. (US) | 2012-02-16 | — | — | WO | disclosed |
| EP-2142549-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM Therapeutics Co., Ltd. (KR) | 2010-01-13 | — | — | EP | disclosed |
| US-20090011359-A1 | LIQUID DEVELOPER | SAKATA INX CORP. (JP) | 2009-01-08 | — | — | US | disclosed |
| WO-2008108508-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM THERAPEUTICS CO., LTD. (KR) | 2008-09-12 | — | — | WO | disclosed |
| EP-0710887-B1 | Photopolymerizable composition | FUJI PHOTO FILM CO LTD (JP) | 1998-07-29 | — | — | EP | disclosed |
| US-5453363-A | Solubilizing, reducing, and denaturing refractile bodies; oxidation with glutathione; genetic engineering | BOEHRINGER MANNHEIM GMBH (DE) | 1995-09-26 | — | — | US | disclosed |
| EP-0265898-B1 | POLYIMIDE GAS SEPARATION MEMBRANES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0265898-A2 | Polyimide gas separation membranes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-04 | — | — | EP | disclosed |
| US-4717394-A | Polyimide gas separation membranes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-01-05 | — | — | US | disclosed |
| EP-0037797-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1981-10-14 | — | — | EP | disclosed |
| EP-0022245-A2 | Aminothiadiazolyl derivatives, process for their preparation, pharmaceutical compositions containing them;starting compounds and process for their preparation | CIBA-GEIGY AG (CH) | 1981-01-14 | — | — | EP | disclosed |